Hu, Leland S.
Wang, Lujia
Hawkins-Daarud, Andrea
Eschbacher, Jennifer M.
Singleton, Kyle W.
Jackson, Pamela R.
Clark-Swanson, Kamala
Sereduk, Christopher P.
Peng, Sen
Wang, Panwen
Wang, Junwen
Baxter, Leslie C.
Smith, Kris A.
Mazza, Gina L.
Stokes, Ashley M.
Bendok, Bernard R.
Zimmerman, Richard S.
Krishna, Chandan
Porter, Alyx B.
Mrugala, Maciej M.
Hoxworth, Joseph M.
Wu, Teresa
Tran, Nhan L.
Swanson, Kristin R.
Li, Jing
Funding for this research was provided by:
National Institutes of Health (U01 CA220378)
Ben and Catherine Ivy Foundation
James S. McDonnell Foundation
Arizona Biomedical Research Commission
Article History
Received: 6 February 2020
Accepted: 18 January 2021
First Online: 16 February 2021
Competing interests
: US Patents: US8571844B2 (KRS); US/International Patent Applications: 63/112,496; 00/00/00 United States; 630666.01125 (LSH, LW, AHD, KRS, TW, JL); 1975745700/00/00 Europe—EPO; 630666.00941EP (LSH, KRS, NLT); 16/975,647; 00/00/00 USA; 630666.01104 (LSH, KRS, NLT, JL, TW); 18878374.0; 00/00/00 Europe—EPO; 630666.01086 (LSH, TW, KRS, JL, AHD); 16/764,837; 00/00/00 USA; 630666.01085 (TW, KRS, JL, LSH, AHD); PCT/US2019/019687; 00/00/00 USA; 630666.00941 (LSH, KRS, NLT, TW, JL); PCT/US2018/061887; 00/00/00 USA; 630666.00920 (LSH, KRS, TW, JL, AHD); 62/684,096; 00/00/00 USA; 630666.00878 (LSH, KRS, TW, JL); 62/635,276; 00/00/00 USA; 630666.00824 (LSH, KRS, NLT); 62/588,096; 00/00/00 USA; 630666.00800 (LSH, JL, KRS, TW); Competing Interests: US Patents: US8571844B2 (KRS). Potential conflicts: Precision Oncology Insights (co-founders KRS, LSH); Imaging Biometrics (medical advisory board, LSH). Remaining co-authors have no conflicts of interest with the content of this article. Potential conflicts: Precision Oncology Insights (co-founders KRS, LSH); Imaging Biometrics (medical advisory board, LSH). Remaining co-authors have no conflicts of interest with the content of this article.